These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 17915298)

  • 1. The canine virtual ventricular wall: a platform for dissecting pharmacological effects on propagation and arrhythmogenesis.
    Benson AP; Aslanidi OV; Zhang H; Holden AV
    Prog Biophys Mol Biol; 2008; 96(1-3):187-208. PubMed ID: 17915298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling changes in transmural propagation and susceptibility to arrhythmia induced by volatile anaesthetics in ventricular tissue.
    Zhang H; Tao T; Kharche S; Harrison SM
    J Theor Biol; 2009 Mar; 257(2):279-91. PubMed ID: 19135456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATX-II effects on the apparent location of M cells in a computational model of a human left ventricular wedge.
    Dos Santos RW; Otaviano Campos F; Neumann Ciuffo L; Nygren A; Giles W; Koch H
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S86-S95. PubMed ID: 16686688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of quinidine on pinacidil-induced transmural dispersion of repolarization in canine right ventricular wall].
    Luo J; Yang XC; Wang LF; Zhou P; Li CL; Wang MS; Gao Y; Wang LZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):369-71. PubMed ID: 15932676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of action potentials in the canine ventricular septum: no phenotypic expression of M cells.
    Morita ST; Zipes DP; Morita H; Wu J
    Cardiovasc Res; 2007 Apr; 74(1):96-103. PubMed ID: 17266946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and antiarrhythmic effects of d-sotalol and dl-sotalol in an isolated tissue model of ischemia and reperfusion.
    Pasnani JS; Ferrier GR
    J Pharmacol Exp Ther; 1994 Oct; 271(1):184-92. PubMed ID: 7965713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms.
    Wilhelms M; Rombach C; Scholz EP; Dössel O; Seemann G
    Europace; 2012 Nov; 14 Suppl 5():v90-v96. PubMed ID: 23104920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and M cells of the canine ventricle.
    Moro S; Ferreiro M; Celestino D; Medei E; Elizari MV; Sicouri S
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):314-21. PubMed ID: 18172226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repolarisation and vulnerability to re-entry in the human heart with short QT syndrome arising from KCNQ1 mutation--a simulation study.
    Zhang H; Kharche S; Holden AV; Hancox JC
    Prog Biophys Mol Biol; 2008; 96(1-3):112-31. PubMed ID: 17905416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transmural electrical heterogeneities and electrotonic interactions on the dispersion of cardiac repolarization and action potential duration: A simulation study.
    Colli Franzone P; Pavarino LF; Taccardi B
    Math Biosci; 2006 Nov; 204(1):132-65. PubMed ID: 16904130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propagation of normal beats and re-entry in a computational model of ventricular cardiac tissue with regional differences in action potential shape and duration.
    Clayton RH; Holden AV
    Prog Biophys Mol Biol; 2004; 85(2-3):473-99. PubMed ID: 15142758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
    Luo C; Wang K; Zhang H
    Biomed Eng Online; 2017 Jun; 16(1):69. PubMed ID: 28592292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure.
    Akar FG; Rosenbaum DS
    Circ Res; 2003 Oct; 93(7):638-45. PubMed ID: 12933704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
    Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
    Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling ventricular repolarization: effects of transmural and apex-to-base heterogeneities in action potential durations.
    Colli Franzone P; Pavarino LF; Scacchi S; Taccardi B
    Math Biosci; 2008; 214(1-2):140-52. PubMed ID: 18621065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramural activation and repolarization sequences in canine ventricles. Experimental and simulation studies.
    Taccardi B; Punske BB; Sachse F; Tricoche X; Colli-Franzone P; Pavarino LF; Zabawa C
    J Electrocardiol; 2005 Oct; 38(4 Suppl):131-7. PubMed ID: 16226088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole heart action potential duration restitution properties in cardiac patients: a combined clinical and modelling study.
    Nash MP; Bradley CP; Sutton PM; Clayton RH; Kallis P; Hayward MP; Paterson DJ; Taggart P
    Exp Physiol; 2006 Mar; 91(2):339-54. PubMed ID: 16452121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
    Kirchhof P; Degen H; Franz MR; Eckardt L; Fabritz L; Milberg P; Läer S; Neumann J; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2003 Apr; 305(1):257-63. PubMed ID: 12649377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.